A Randomized Controlled Study Comparing the Efficacy of QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated Non-small Cell Lung Cancer
Latest Information Update: 21 Jan 2026
At a glance
- Drugs Iparomlimab/tuvonralimab (Primary) ; Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Jan 2026 New trial record